Fig. 1From: Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trialTemporal and dose-associated improvements in (a) FPG and (b) HbA1c stratified according to the month 6 gliclazide MR dose. *P < 0.001 for the difference between corresponding baseline and month 6 FPG and HbA1c values. FPG and HbA1c values are presented as mean (SD)Back to article page